303. Intravenous ketorolac substantially reduces opioid use following lumbar spinal fusion: early results of a randomized, double-blinded, placebo controlled trial

Sravisht Iyer; Evangelia M. Zgonis; Michael E. Steinhaus; Jeffrey Varghese; Dan Joseph Stein; Jingyan Yang; Todd J. Albert; Frank J. Schwab; Darren R. Lebl; Han Jo Kim; Matthew E. Cunningham; James C. Farmer; Federico P. Girardi; Russel C. Huang; Sheeraz A. Qureshi; Bernard A. Rawlins; James D. Beckman; Harvinder S. Sandhu

doi:10.1016/j.spinee.2019.05.320

Related publications

Article2019

2017 Research Grant: Intravenous ketorolac substantially reduces opioid use following lumbar spinal fusion: early results of a randomized, double-blinded, placebo controlled trial

Sravisht Iyer, Evangelia M. Zgonis, Michael E. Steinhaus, Jeffrey Varghese, Dan Joseph Stein, Jingyan Yang, Todd J. Albert, Frank Schwab, Darren R. Lebl, Han Jo Kim, Matthew E. Cunningham, James C. Farmer, Federico P. Girardi, Russel C. Huang, Sheeraz A. Qureshi, Bernard A. Rawlins, James D. Beckman, Harvinder S. Sandhu

Article2009

N-acetylcysteine as adjunctive treatment in severe malaria: A randomized, double-blinded placebo-controlled clinical trial*

Prakaykaew Charunwatthana, Maryam Faiz, Ronnatrai Ruangveerayut, Richard J. Maude, Mushfiqur Rahman, L. Jackson Roberts, Kevin Moore, Emran Bin Yunus, M. Gofranul Hoque, Mahatab Uddin Hasan, Sue J. Lee, Sasithon Pukrittayakamee, Paul N. Newton, Sir Nicholas White, Nicholas Day, Arjen M. Dondorp

Critical Care Medicine

Article2021

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19

Mohammad Bosaeed, Ahmad M. Alharbi, Mohammad H. Hussein, Mohammed Abalkhail, Khizra Sultana, Abrar Musattat, Hajar AlQahtani, Majid M. Alshamrani, Ebrahim Mahmoud, Adel Alothman, Abdulrahman Alsaedy, Omar Aldibasi, Khalid Alhagan, Abdullah Mohamed Asiri, Sameera Aljohani, Majed Al-Jeraisy, Ahmed Alaskar

Article2021

Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)*

Suzie Cro, Victoria Cornelius, Andrew Pink, Rebecca Wilson, Angela Pushpa‐Rajah, Prakash A. Patel, Alya Abdul‐Wahab, S. August, J. Azad, G Becher, Anna Chapman, Giles Dunnill, Adam Ferguson, A. Fogo, S.A. Ghaffar, John R Ingram, Svetlana Kavakleiva, E. Ladoyanni, Joyce Leman, A. E. Macbeth, Areti Makrygeorgou, Richard Parslew, Alan J. Ryan,

Article2022

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

Mrinal M. Gounder, Albiruni Abdul Razak, Neeta Somaiah, Sant P. Chawla, Javier Martín‐Broto, Giovanni Grignani, Scott M. Schuetze, Bruno Vincenzi, Andrew J. Wagner, Bartosz Chmielowski, Robin L. Jones, Richard F. Riedel, Silvia Stacchiotti, Elizabeth T. Loggers, Kristen N. Ganjoo, Axel Le Cesne, Antoîne Italiano, Xavier García del Muro, Melissa Burgess, Sophie Piperno‐Neumann, Christopher W. Ryan, Mary F. Mulcahy, Charles Forscher,